Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by Dollarfigureon May 25, 2010 7:06pm
669 Views
Post# 17130338

Corporate UPDATE just released!!!

Corporate UPDATE just released!!!2010-05-25 07:18 ET - News Release Stem Cell's

Now wonder the stock sold off days ago?? someone was smart enough at the company to spend $10 and buy a tester!! We don't know why the stock is selling off days before the worst news ever?? Investigation? who will resign? lol

Bullboard Posts